Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kalra

Showing results (371-380 of 486) with videos related to

Pageof 49
Sort By:
BMC Nephrology|March 24, 2021
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidismHelen Eddington, Rajkumar Chinnadurai, Helen Alderson, et al.
The World Journal of Men'S Health|April 7, 2026
Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort StudyLino Merlino, Francesco Rainone, James Tollitt, et al.
Clinical Kidney Journal|July 8, 2026
Pre-existing anxiety and mood disorders and multisystem outcomes in young adults with chronic kidney diseaseLino Merlino, Francesco Rainone, James Tollit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2015
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patientsSunil Bhandari, Philip A Kalra, Jatin Kothari, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney diseaseVasim Farooq, Janet Hegarty, Thangavelu Chandrasekar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 14, 2005
The unrecognized prevalence of chronic kidney disease in diabetesRachel J Middleton, Robert N Foley, Janet Hegarty, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipientP A Kalra, G N Wood, D J O'Donoghue, et al.
Plos One|October 15, 2015
Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic ReviewAndrew J Sutton, Katie Breheny, Jon Deeks, et al.
Plos Medicine|February 29, 2020
Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort studyAnthony Fenton, Rajkumar Chinnadurai, Latha Gullapudi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 7, 2010
Serum phosphate and mortality in patients with chronic kidney diseaseHelen Eddington, Richard Hoefield, Smeeta Sinha, et al.
Pageof 49

Showing results (371-380 of 486) with videos related to

Sort By:
Pageof 49
BMC Nephrology|March 24, 2021
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidismHelen Eddington, Rajkumar Chinnadurai, Helen Alderson, et al.
The World Journal of Men'S Health|April 7, 2026
Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort StudyLino Merlino, Francesco Rainone, James Tollitt, et al.
Clinical Kidney Journal|July 8, 2026
Pre-existing anxiety and mood disorders and multisystem outcomes in young adults with chronic kidney diseaseLino Merlino, Francesco Rainone, James Tollit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2015
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patientsSunil Bhandari, Philip A Kalra, Jatin Kothari, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney diseaseVasim Farooq, Janet Hegarty, Thangavelu Chandrasekar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 14, 2005
The unrecognized prevalence of chronic kidney disease in diabetesRachel J Middleton, Robert N Foley, Janet Hegarty, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipientP A Kalra, G N Wood, D J O'Donoghue, et al.
Plos One|October 15, 2015
Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic ReviewAndrew J Sutton, Katie Breheny, Jon Deeks, et al.
Plos Medicine|February 29, 2020
Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort studyAnthony Fenton, Rajkumar Chinnadurai, Latha Gullapudi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 7, 2010
Serum phosphate and mortality in patients with chronic kidney diseaseHelen Eddington, Richard Hoefield, Smeeta Sinha, et al.
Pageof 49